Sopherion Therapeutics

closed

Sopherion has the US and Canadian rights to this liposomal nanotechnology that targets the tumor vasculature.

HQ location

New Brunswick, United States

Website

Launch date

2001

Employees

Enterprise value

$188—282m

https://www.linkedin.com/company/sopherion-therapeutics

Get premium to view all results

Date	Investors	Amount	Round
Mar 2003	investor investor investor investor investor investor investor investor	€0.0	round
Sep 2004	investor investor investor investor investor investor investor	€0.0	round
Jan 2008	investor investor investor investor investor investor investor	€0.0	round
Feb 2009	Zoticon BioVentures	$55.0m	Series C
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads

Tech stackLearn more about the technologies and tools that this company uses.